SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $636,000 | -81.4% | 56,996 | -81.7% | 0.00% | -100.0% |
| Q2 2017 | $3,417,000 | +477.2% | 310,799 | +413.4% | 0.00% | – |
| Q1 2017 | $592,000 | -25.5% | 60,543 | -17.9% | 0.00% | -100.0% |
| Q4 2016 | $795,000 | -37.3% | 73,770 | -40.4% | 0.00% | 0.0% |
| Q3 2016 | $1,267,000 | -7.7% | 123,742 | +17.7% | 0.00% | 0.0% |
| Q2 2016 | $1,372,000 | +3.8% | 105,162 | -12.6% | 0.00% | 0.0% |
| Q1 2016 | $1,322,000 | +453.1% | 120,347 | +360.4% | 0.00% | – |
| Q4 2015 | $239,000 | -37.4% | 26,138 | -52.6% | 0.00% | – |
| Q3 2015 | $382,000 | -61.2% | 55,161 | -45.0% | 0.00% | -100.0% |
| Q2 2015 | $985,000 | +87.6% | 100,365 | +69.0% | 0.00% | – |
| Q1 2015 | $525,000 | +79.8% | 59,399 | +77.5% | 0.00% | – |
| Q4 2014 | $292,000 | +84.8% | 33,472 | +45.2% | 0.00% | – |
| Q3 2014 | $158,000 | -44.9% | 23,049 | -57.8% | 0.00% | – |
| Q2 2014 | $287,000 | +54.3% | 54,637 | +33.0% | 0.00% | – |
| Q1 2014 | $186,000 | +21.6% | 41,080 | +34.6% | 0.00% | – |
| Q4 2013 | $153,000 | -81.0% | 30,531 | -80.8% | 0.00% | -100.0% |
| Q3 2013 | $805,000 | – | 158,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|